WWW . C L I N I C A L C H A L L E NG E S I N I B D . C OM

Saturday, July 23, 2016

CHICAGO, ILLINOISChair

David T. Rubin, MD, FACG, AGAF University of Chicago Medicine Chicago, Illinois

Individualizing our Approach to IBD

MASTERING CLINICAL CHALLENGES AND EMERGING THERAPIES IN IBD

Learning Objectives

After successful completion of this activity, participants should be able to:

• Analyze controversial issues in the multidisciplinary management of IBD to formulate optimal therapeutic algorithms, with considerations for special patient populations and bene� ts and risks of treatment options

• Plan e� ective treatment for patients with IBD based on careful risk assessment and targeted patient selection

• Evaluate and select evidence-based treatment regimens that may improve patient outcomes and quality of care

Who Should Attend

This educational activity is specifically designed for gastroenterologists, hospitalists, internal medicine specialists, and other healthcare professionals (physicians-in-training, nurses, pharmacists, physicians assistants, etc.) involved and/or interested in the therapeutic management of patients with IBD.

Continuing Medical Education

Imedex®, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

This activity has been approved for AMA PRA Category 1 Credit™.

LOC

ATI

ON

AN

D A

CC

OM

MO

DA

TIO

NS

The

Gw

en H

ote

l 52

1 N

. Ru

sh S

tree

t, C

hic

ago,

Illin

ois

606

11

Tel.:

+1

(312

) 645

150

0 w

ww

.theg

wen

chic

ago.

com

Reg

iste

r b

y Ju

ly 7

, 20

16

an

d s

ave!

+1

(80

0) 2

33

-09

57

|

ww

w.c

linic

alch

alle

ng

esin

ibd

.co

m

Up-to

-dat

e Man

agem

ent S

trate

gies

for I

BDM

idw

este

rn m

edic

al p

rofe

ssio

nal

s, w

e’ve

go

t so

met

hin

g fo

r yo

u. N

ew fi

nd

ing

s, n

ew te

chn

iqu

es, a

nd

rece

nt

effo

rts

in re

sear

ch a

nd

dis

cove

ry h

ave

chan

ged

th

e w

ay p

hys

icia

ns

trea

t th

eir p

atie

nts

– t

akin

g a

mo

re in

div

idu

aliz

ed

app

roac

h. M

aste

rin

g C

linic

al C

hal

len

ges

an

d E

mer

gin

g T

her

apie

s in

IBD

will

pro

vid

e im

po

rtan

t cl

inic

al u

pd

ates

in t

he

man

agem

ent

of p

atie

nts

wit

h in

flam

mat

ory

bo

wel

dis

ease

.

Lect

ures

to in

clud

e:•

Evol

ving

app

roac

hes t

o cu

rren

t clin

ical

cha

lleng

es

• W

hat a

re th

e fa

ctor

s tha

t sho

uld

influ

ence

cho

ice

of fi

rst

ther

apy

in IB

D? U

nder

stan

ding

long

itudi

nal s

ever

ity

• H

ealin

g th

e bo

wel

: How

to d

o it,

how

to k

now

you

’ve

got i

t

• Se

lect

ion

and

use

of th

e no

n-an

ti-TN

F bi

olog

ical

th

erap

ies:

Who

? Whe

n? H

ow?

• U

pdat

e on

ther

apeu

tic d

rug

mon

itorin

g in

IBD

: Is i

t tim

e w

e us

e it

in si

tuat

ions

oth

er th

an lo

ss o

f res

pons

e?

• D

ecis

ion-

mak

ing

and

risk

disc

ussi

ons i

n IB

D:

W

ho h

as ti

me?

• D

yspl

asia

in IB

D, c

an w

e ge

t aw

ay w

ith su

btot

al

cole

ctom

y w

ith m

oder

n vi

sual

izat

ion

tech

niqu

es?

• Im

prov

ing

care

in y

our p

ract

ice

and

for s

peci

fic

patie

nt ty

pes

• Q

ualit

y of

car

e in

IBD

: How

do

you

get i

t in

yo

ur p

ract

ice?

• I m

plem

entin

g a

Qua

lity

of C

are

proj

ect:

Acce

ss to

urg

ent

care

at t

he U

nive

rsity

of C

hica

go

Case

dis

cuss

ions

to in

clud

e:•

Clos

trid

ium

diffi

cile

in a

ctiv

e IB

D: W

hich

cam

e fir

st a

nd h

ow d

o yo

u tr

eat?

• Th

e ho

spita

lized

Cro

hn’s

dise

ase

patie

nt

• T h

e po

st-o

p Cr

ohn’

s pa

tient

• Re

frac

tory

pro

ctiti

s: n

ovel

app

roac

hes

for a

diffi

cult

prob

lem

• P e

risto

mal

pyo

derm

a: W

hat n

ow?

SUP

PO

RT:

Sev

eral

op

tio

ns

are

avai

lab

le to

co

mp

anie

s in

tere

sted

in

su

pp

ort

ing

th

is c

on

fere

nce

. Fo

r mo

re in

form

atio

n, p

leas

e co

nta

ct

Imed

ex a

t +

1 (6

78) 2

42 0

719

or b

y em

ail a

t cm

e@im

edex

.co

m.

EXH

IBIT

OR

S: E

xhib

it s

pac

e an

d s

up

po

rt o

pti

on

s ar

e av

aila

ble

.

For m

ore

info

rmat

ion

, co

nta

ct Im

edex

at

+1

(678

) 242

071

9 o

r ex

hib

its@

imed

ex.c

om

.

MA

INTE

NA

NC

E O

F C

ERTI

FIC

ATI

ON

(MO

C):

Succ

essf

ul

com

ple

tion

of t

his

CM

E ac

tivi

ty e

nab

les

a p

arti

cip

ant t

o ea

rn M

OC

poi

nts

to

war

ds

the

Am

eric

an B

oard

of I

nte

rnal

Med

icin

e’s

(ABI

M) M

ain

ten

ance

of

Cer

tific

atio

n (M

OC

) pro

gra

m. P

arti

cip

ants

will

ear

n M

OC

poi

nts

eq

uiv

alen

t to

the

amou

nt o

f CM

E cr

edit

s cl

aim

ed fo

r th

e ac

tivi

ty. I

t is

Imed

ex’s

resp

onsi

bili

ty to

su

bm

it p

arti

cip

ant c

omp

leti

on in

form

atio

n to

A

CC

ME

for t

he

pu

rpos

e of

gra

nti

ng

ABI

M M

OC

Poi

nts

.

MAS

TERI

NG C

LINI

CAL

CHAL

LENG

ES

AND

EMER

GIN

G T

HERA

PIES

IN IB

D In

divi

dual

izin

g ou

r App

roac

h to

IBD

Satu

rday

, Ju

ly 2

3, 2

016

| Ch

icag

o, IL

| T

he G

wen

Hot

el

1167

5 Ra

inw

ater

Driv

e, S

uite

600

Al

phar

etta

, GA

3000

9, U

SA

Lear

n pr

actic

al a

pplic

atio

ns

for u

se in

you

r clin

ic